GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% logo.

The most prescribed IG in the US for 15+ years1

(Based on combined data from PI*)

*Based on combined data for PI & MMN. Internal calculations by Takeda based on Marketing Research Bureau (MRB) database of total IG units prescribed (2006-2023).

GAMMAGARD LIQUID was approved for PI in 2005, MMN in 2012, and CIDP in 2024.

GAMMAGARD LIQUID is indicated as a replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age or older, as a maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN), and as a therapy to improve neuromuscular disability and impairment in adult patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). 

LIMITATIONS OF USE (CIDP): GAMMAGARD LIQUID has not been studied in immunoglobulin-naïve patients with CIDP. GAMMAGARD LIQUID maintenance therapy in CIDP has not been studied for periods longer than 6 months. After responding during an initial treatment period, not all patients require indefinite maintenance therapy with GAMMAGARD LIQUID in order to remain free of CIDP symptoms. Individualize the duration of any treatment beyond 6 months based upon the patient’s response and demonstrated need for continued therapy.

Learn more about GAMMAGARD LIQUID for

GAMMAGARD LIQUID: an established IG with a long-standing history in primary immunodeficiency (PI)

GAMMAGARD LIQUID was approved for PI in 2005, MMN in 2012, and CIDP in 2024. 

Globe icon.

16,000+

people infused
GAMMAGARD LIQUID
in 2023

20 years experience icon.

20+

years of real-world
experience§

Infusion bag icon.

2,253,688

infusions

Calculations based on units of GAMMAGARD LIQUID sold in PI from 2006-2023, assuming an average utilization of 450 g/yr/patient and 12 infusions/yr/patient.

IG=immune globulin.  

Blue-orange coverage card icon.

Access and Coverage Resources

Vial icon.

Vial Sizes and Storage

Star medal icon.

Takeda's Commitment

Envelope icon.

Stay up to date on GAMMAGARD LIQUID for PI, MMN, and CIDP

REFERENCE

  1. Marketing Research Bureau (MRB) database of total IG Units prescribed based on combined data (2006-2023).